Naplasol, a member of the VEOS Group, acquires the Swedish mycoprotein company, Mycorena

Naplasol, a member of the VEOS Group, has announced the acquisition of the Swedish mycoprotein company Mycorena. This strategic move will strengthen Naplasol's position in the mycoprotein market and expand its product offerings for the food, pet-food, and feed industries.

Mycorena, a pioneer in mycoprotein technology, has developed Promyc, a high-quality and sustainable mycoprotein ingredient. Promyc is known for its neutral taste and strong fibrous texture, making it a versatile option for various food applications.

"Both Naplasol and Mycorena share a common goal of providing sustainable and nutritious protein solutions," commented Wim Slee, Co-CEO of VEOS Group. "By combining our expertise and resources, we can accelerate the development and commercialization of innovative mycoprotein products."

Ramkumar Nair PhD, Founder of Mycorena, expressed his enthusiasm about the acquisition: "We look forward to seeing Mycorena continue to thrive under the strong industrial expertise of the Veos Group," said Ramkumar Nair."

Naplasol, a subsidiary of VEOS Group, is a leading producer of essential proteins through fermentation technology. The company has a strong track record of delivering high-quality protein ingredients to customers worldwide. With the acquisition of Mycorena, Naplasol will further expand its portfolio and solidify its position as a key player in the mycoprotein market.

Mycoproteins are gaining popularity as a sustainable and nutritious alternative to traditional protein sources. They have a lower environmental footprint compared to animal-based proteins and offer a variety of health benefits. The acquisition of Mycorena by Naplasol is a significant step towards making mycoproteins more accessible to consumers.

The combined strengths of Naplasol and Mycorena will enable them to develop innovative mycoprotein-based products that meet the evolving needs of consumers. By leveraging their expertise in fermentation technology and mycoprotein production, the companies aim to drive the growth of the mycoprotein market and contribute to a more sustainable food system.